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Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biom-
arker secreted in the atherosclerotic plaque. The main objective of this study is
to compare Lp-PLA2 with CCA in AS-patients prior to aortic valve surgery and
to evaluate Lp-PLA2 as an independent predictor of associated CAD.
Methods and Results: 285 patients with AS and/or CAD were included
into 3 groups: “CAD-Group”: stable CAD; “AS-Group”: AS and normal cor-
onary arteries and “AS-CAD-Group”: AS and stable CAD associated. Lp-
PLA2 mass concentration was assessed in serum with a Plac®-test turbidi-
metric immunoassay. Normal Lp-PLA2 values of the lipids laboratory were
specifically obtained from 61 healthy Caucasian volunteers.
In healthy controls, Lp-PLA2 was 163±43 μg/L. Lp-PLA2 was signifi-
cantly higher in patients than in controls (219.2±49.1 vs 163.0±43.0 μg/L;
p=0.01) and was significantly higher in the AS-CAD group (246±51 μg/L,
p<0.001) than in the 2 other groups (AS: 217±44; CAD: 215±48 μg/L). Lp-
PLA2 appeared to be an independent prognostic factor for CAD in patients
with AS (total r=0.76; p=0.005) with a rule-out value of 230 µg/L. Lp-PLA2
was found to have 80.1% sensitivity, 58.6% specificity to separate AS with or
without CAD, while PPV and NPV were 70% and 58%, respectively.
Conclusion: Our results suggest that in patients with severe AS, Lp-
PLA2 could correlate with associated stable CAD, with a rule-out value of
230 µg/L, and may be helpful to select patients requiring coronary angio-
graphy before cardiac valve surgery.
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Objectives: The purpose of this study was to evaluate the efficacy and
safety of transcatheter aortic valve implantation (TAVI) in patients with small
body size (SB).
Background: Clinical outcome of TAVI in patients with SB remains unclear.
Methods: Between October 2006 and November 2011, 424 patients with
severe aortic stenosis undergoing TAVI were evaluated. The cohort with small
body surface area of <1.75 m2 was defined as the “SB group” (n=215) and the
rest of the cohort with large body-size as the “LB group” (n=209). 
Results: In the SB group, the aortic annulus and femoral artery diameter
were significantly smaller (23.0±1.86 vs 24.3±1.94 mm, p <0.001; 7.59±1.06 vs
8.29±1.34 mm, p <0.001, respectively). The logistic EuroSCORE was similar
between the groups (22.5±10.4 vs 23.4±12.0, p=0.433). Equivalent device suc-
cess (91.2 vs 91.4%, p=0.935) and 30-day survival rates (85.1 vs 87.6%,
p=0.464) were achieved in both groups. Vascular complications were signifi-
cantly higher in the SB group (13.0% vs 4.3%, p=0.002). Similar post-proce-
dural mean pressure gradient was achieved in both groups (10.2±4.3 vs 11.0±4.6
mmHg, p=0.119). Kaplain-Meier survival analysis revealed no significant dif-
ference in the mid-term survival between groups (log-rank p=0.642). 
Conclusions: TAVI in patients with SB resulted in similar clinical out-
comes with effective post-procedural hemodynamics compared with LB. Care
should be taken to avoid vascular complication in patients with SB.
169
Body mass index: a gender related risk factor for late mortality in
patients undergoing aortic valve replacement?
Ewa Orlowska-Baranowska (1), Rafal Baranowski (2), Elzbieta
Abramczuk (1), Tomasz Hryniewiecki (1)
(1) Institute of Cardiology, Valvular Heart Dieseases, Warsaw, Pologne –
(2) Institute of Cardiology, Warsaw, Pologne
In recent studies, the impact of a low or high body mass index (BMI)
on outcome after cardiac surgery has been the subject of controversy. Our
study was conducted to determine the influence of BMI on late mortality
after aortic valve replacement (AVR) in pts with significant aortic stenosis
(AS).
Methods: 1150 pts (42% women, mean age of 6510 yrs) were observed
mean 7,54 yrs (40 days to 13 yrs) after AVR due to significant, isolated
AS (99% complete). BMI was divided in three groups: <25 kg/m2
(478 pts), 25-30 kg/m2 (472 pts) and >35 kg/m2 (200 pts). During 10 yrs
221 deaths were recorded – 70 women (14,6%) and 151 men (22,7%) –
p=0,001. 
Results: Kaplan-Meier analysis of survival was assessed. The differences
were observed in whole group (0,04) and in men (p=0,001) but not in women
(NS). Male patients with BMI <25 and>30 kg/m2 had higher risk of death in
comparison to those with BMI 25-30 kg/m2.
Conclusion: The survival after aortic valve replacement is related to body
mass index only in male patients – BMI <25 kg/m2 and >30 kg/m2 is predic-
tive of an increased risk of late mortality.
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It has been shown during the past few years that woman’s heart is different
than man’s. It is stressed, that women are on increased risk of aortic valve
replacement (AVR) due to greater hypertrophy and worse its regression.
Objective: The aim of the study was to estimate whether the survive after
AVR is gender related or there are any other parameters which have impact
on follow up after surgery in aortic stenosis (AS). 
Methodology: 993 pts (408 women, age 65±10 yrs) after AVR due to AS
were observed mean 7,5±4 yrs after surgery. Following parameters were taken
into account: gender, age, significance of AS (transaortic gradient – MAG),
left ventricle hypertrophy (mass index- LVMI), ejection fraction (EF) and
presence of coronary artery stenosis (CAD) assessed before AVR.
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